+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyperpigmentation Disorders Treatment Market by Disease Type, Treatment Type, Skin Tone, Application, Distribution Channel, End-use - Global Forecast to 2030- Product Image
Hyperpigmentation Disorders Treatment Market by Disease Type, Treatment Type, Skin Tone, Application, Distribution Channel, End-use - Global Forecast to 2030- Product Image
Sale

Hyperpigmentation Disorders Treatment Market by Disease Type, Treatment Type, Skin Tone, Application, Distribution Channel, End-use - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889071
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hyperpigmentation disorders treatment market is undergoing rapid transformation, driven by evolving patient expectations, technological advances, and changing global trade conditions. Senior decision-makers seeking strategic insights and pathways to sustained market leadership will find new opportunities at the intersection of clinical innovation and accessible care.

Market Snapshot: Hyperpigmentation Disorders Treatment Market

The Hyperpigmentation Disorders Treatment Market grew from USD 1.51 billion in 2024 to USD 1.60 billion in 2025. It is expected to continue growing at a CAGR of 5.82%, reaching USD 2.13 billion by 2030. This consistent upward trajectory reflects a rising demand for targeted therapies, increased adoption of minimally invasive procedures, and expanding access to advanced solutions worldwide. Stakeholders from pharmaceutical, device, and aesthetic service sectors are capitalizing on emerging therapeutic modalities that address consumer priorities across diverse populations.

Scope & Segmentation: Comprehensive Market Coverage

  • Disease Types: Ephelides (freckles), all forms of melasma (dermal, epidermal, mixed), post-inflammatory hyperpigmentation, solar lentigines.
  • Treatment Modalities: Chemical peels (alpha hydroxy acid, beta hydroxy acid, trichloroacetic acid), advanced laser therapies (fractional, Nd:YAG, Q-Switch), oral medication, topical medication (azelaic acid, hydroquinone creams, retinoids).
  • Skin Tone Applications: Fitzpatrick types I–VI, ensuring treatment optimization for light to dark skin tones.
  • Key Applications: Acne scar treatment, age spot lightening, dark circle correction, melasma reduction, sun spot fading.
  • Distribution Channels: Offline retailers and online retailers, with both brick-and-mortar and e-commerce strategies contributing to product accessibility and market expansion.
  • End-Use Settings: Aesthetic centers, dermatology clinics, hospitals, and specialty clinics, offering multiple patient engagement and service delivery models.
  • Regional Coverage: Americas—including United States, Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa—including major markets such as United Kingdom, Germany, France, Italy, Russia, UAE, South Africa; Asia-Pacific—including China, India, Japan, Australia, South Korea, and Southeast Asian economies.
  • Industry Leaders: Major participants include global pharmaceutical companies, laser device manufacturers, multinational skincare brands, and innovative biotech firms such as AbbVie Inc., Lumenis Be Ltd., Galderma S.A., ZO Skin Health, Inc., and others.

Key Takeaways: Strategic Insights for Market Leaders

  • Technological advances are enabling precise and personalized treatments, with innovations in lasers, topical agents, and digital diagnostics improving patient outcomes and reducing downtime.
  • Collaborative partnerships among dermatologists, device OEMs, and pharmaceutical formulators are driving the development of combination regimens that improve treatment efficacy and patient satisfaction.
  • The convergence of teledermatology and online retail is expanding access to professional care—facilitating penetration into previously underserved markets and supporting omnichannel strategies that align with shifting patient behaviors.
  • Awareness initiatives and regulatory harmonization efforts, particularly in EMEA and Asia-Pacific regions, are supporting adoption of novel therapies and opening new pathways for market entry and growth.
  • Product portfolios tailored to skin type diversity—especially Fitzpatrick types V and VI—are critical for risk mitigation and maximizing addressable market share as demand for inclusive solutions grows.

Tariff Impact on the Hyperpigmentation Treatment Sector

Revised U.S. tariff schedules that took effect in 2025 have influenced import costs for dermatological devices, chemical agents, and topical products. Increased duties on laser components have prompted a shift in manufacturing strategies, affecting supply chain arrangements and equipment procurement by aesthetic centers. Chemical ingredient tariffs are encouraging domestic sourcing and supporting innovation in local formulation chemistry, promoting resilience across the value chain. These dynamics are reshaping sourcing approaches, pricing models, and regional investment decisions for manufacturers and distributors alike.

Methodology & Data Sources

This report draws on a rigorous blend of primary interviews, field surveys, expert panels, and secondary research including peer-reviewed publications, patent reviews, regulatory filings, and corporate disclosures. Data reliability is ensured through triangulation of shipment, procurement, and utilization trends, supported by periodic peer validation and review cycles.

Why This Report Matters for Decision-Makers

  • Unlocks actionable insights on technology trends, partnership models, and market entry strategies to guide robust investment and innovation decisions.
  • Supports operational resilience and growth by clarifying the effects of policy shifts and regulatory developments on sourcing and channel management.
  • Provides a data-driven basis for aligning product portfolios with regional demands, patient diversity, and the shifting competitive environment.

Conclusion

The hyperpigmentation disorders treatment market is set for significant advancement as science, technology, and patient needs converge. Informed strategic planning, flexible sourcing, and adaptive go-to-market strategies are essential for capturing emerging opportunities and sustaining competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding geriatric population contributing to higher instances of age-related hyperpigmentation issues
5.1.1.2. Growing consumer awareness about skin health propelling demand for pigmentation disorder solutions
5.1.1.3. Increasing prevalence of hyperpigmentation due to lifestyle factors driving treatment market growth
5.1.2. Restraints
5.1.2.1. Rising concerns associated with adverse side effects in hyperpigmentation treatments across diverse skin types
5.1.3. Opportunities
5.1.3.1. Increasing investing in research and development to discover new compounds and technologies for more effective results
5.1.3.2. Expansion of teledermatology services for remote treatment and consultation of hyperpigmentation
5.1.4. Challenges
5.1.4.1. Availability of alternative and natural remedies impacting pharmaceutical treatment adoption Opportunities
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Rising prevalence of melasma globally necessitating advanced hyperpigmentation disorders treatments
5.2.2. End-use: Increasing demand for hyperpigmentation disorder treatments across expanding dermatology clinics
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Hyperpigmentation Disorders Treatment Market, by Disease Type
6.1. Introduction
6.2. Ephelides (Freckles)
6.3. Melasma
6.3.1. Dermal Melasma
6.3.2. Epidermal Melasma
6.3.3. Mixed Melasma
6.4. Post-Inflammatory Hyperpigmentation
6.5. Solar Lentigines
7. Hyperpigmentation Disorders Treatment Market, by Treatment Type
7.1. Introduction
7.2. Chemical Peels
7.2.1. Alpha Hydroxy Acid Peels
7.2.2. Beta Hydroxy Acid Peels
7.2.3. Trichloroacetic Acid Peels
7.3. Laser Therapy
7.3.1. Fractional Laser
7.3.2. Nd:YAG Laser
7.3.3. Q-Switch Laser
7.4. Oral Medication
7.5. Topical Medication
7.5.1. Azelaic Acid
7.5.2. Hydroquinone Creams
7.5.3. Retinoids
8. Hyperpigmentation Disorders Treatment Market, by Skin Tone
8.1. Introduction
8.2. Fitzpatrick skin type V & VI
8.3. Fitzpatrick skin type | & |I
8.4. Fitzpatrick skin type ||I & IV
9. Hyperpigmentation Disorders Treatment Market, by Application
9.1. Introduction
9.2. Acne Scar Treatment
9.3. Age Spot Lightening
9.4. Dark Circle Correction
9.5. Melasma Reduction
9.6. Sun Spot Fading
10. Hyperpigmentation Disorders Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Offline Retailers
10.3. Online Retailers
11. Hyperpigmentation Disorders Treatment Market, by End-use
11.1. Introduction
11.2. Aesthetic Centers
11.3. Dermatology Clinics
11.4. Hospitals & Specialty Clinics
12. Americas Hyperpigmentation Disorders Treatment Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Hyperpigmentation Disorders Treatment Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Hyperpigmentation Disorders Treatment Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. The innovative launch of MintyBright Nu offers a natural solution for safe skin brightening and even tone care.
15.3.2. Strategic acquisition by LIAN Group strengthens global presence in hyperpigmentation treatment industry
15.3.3. L’Oréal unveils Melasyl for advanced hyperpigmentation treatment
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. HYPERPIGMENTATION DISORDERS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. HYPERPIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 17. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
FIGURE 19. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. HYPERPIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HYPERPIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY EPHELIDES (FRECKLES), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMAL MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY EPIDERMAL MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MIXED MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY POST-INFLAMMATORY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SOLAR LENTIGINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ALPHA HYDROXY ACID PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY BETA HYDROXY ACID PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TRICHLOROACETIC ACID PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY FRACTIONAL LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ND:YAG LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY Q-SWITCH LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY AZELAIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYDROQUINONE CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY FITZPATRICK SKIN TYPE V & VI, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY FITZPATRICK SKIN TYPE | & |I, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY FITZPATRICK SKIN TYPE ||I & IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY AGE SPOT LIGHTENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DARK CIRCLE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SUN SPOT FADING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY OFFLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY AESTHETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 83. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 85. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 86. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 88. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 93. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 135. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 137. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 138. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 139. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 140. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 145. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 147. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 148. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 149. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 150. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 163. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 165. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 167. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 168. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 169. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 170. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 223. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 224. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 225. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 227. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 228. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 229. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 230. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 256. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 257. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 259. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 260. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 261. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 265. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 266. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 269. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 270. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 275. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 276. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 278. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 279. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TOPICAL MEDICATION, 2018-2030 (USD MILLION)
TABLE 280. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY SKIN TONE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 284. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 285. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, 2018-2030 (USD MILLION)
TABLE 286. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, 2018-2030 (USD MILLION)
TABLE 288. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, 2018-2030 (USD MILLION)
TABLE 289. FRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hyperpigmentation Disorders Treatment market report include:
  • AbbVie Inc.
  • Aerolase Corporation
  • Asclepion Laser Technologies GmbH
  • Bayer AG
  • BIODERMA
  • Candela Corporation by El.En.
  • Cosderma Cosmetology Institute
  • Cynosure LLC
  • Epipharm AG
  • Fade Out Ltd.
  • Galderma S.A.
  • L'oreal S.A.
  • Lumenis Be Ltd.
  • Lynton Lasers Ltd.
  • Mesoestetics
  • Niche Beauty Lab, S.L.
  • Obagi Cosmeceuticals LLC
  • PCA Skin by Colgate Palmolive Company
  • Pierre Fabre Group
  • Pureplay Skin Sciences (India) Private Limited
  • Science of Skincare, LLC
  • Skin Laundry Holdings LLC
  • Skincare by Dr V
  • ZO Skin Health, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.13 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Indication (Age Spots, Melasma), By Treatment (Chemical Peels, Energy-based Therapy, Microdermabrasion, Microneedling), By Skin Tone, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Indication (Age Spots, Melasma), By Treatment (Chemical Peels, Energy-based Therapy, Microdermabrasion, Microneedling), By Skin Tone, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 145 Pages
  • Global
From
Hyperpigmentation Disorders Treatment - Global Strategic Business Report - Product Image

Hyperpigmentation Disorders Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Hyperpigmentation Disorder Treatment Market Report 2025 - Product Image

Hyperpigmentation Disorder Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chemical Peel Market Size, Share & Trends Analysis Report by Product (Lactic Peel, Fruit Peel), Type (Superficial Or Light Peel, Medium Peel), Application (Hyperpigmentation, Dark Circles, Wrinkles), End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Chemical Peel Market Size, Share & Trends Analysis Report by Product (Lactic Peel, Fruit Peel), Type (Superficial Or Light Peel, Medium Peel), Application (Hyperpigmentation, Dark Circles, Wrinkles), End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 80 Pages
  • Global
From
China Skin Analyzers Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, Spectrum Type, and End User - Product Image

China Skin Analyzers Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, Spectrum Type, and End User

  • Report
  • 83 Pages
  • China, Global
From

About the Market

The Hyperpigmentation Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Hyperpigmentation Drugs are used to treat conditions such as melasma, age spots, and post-inflammatory hyperpigmentation. These drugs are typically topical creams, lotions, or gels that contain active ingredients such as hydroquinone, tretinoin, and corticosteroids. These drugs work by inhibiting the production of melanin, the pigment that causes dark spots on the skin. The Hyperpigmentation Drug market is highly competitive, with many companies offering products that contain different active ingredients. Some of the major players in the market include Galderma, Allergan, and Johnson & Johnson. Other companies in the market include Valeant Pharmaceuticals, Merck, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.